Featured Products

Actigen is one step closer to conducting clinical trials in the US for a potential breakthrough in rare disease treatment, following a recent positive pre-Investigational New Drug meeting with the US Food and Drug Administration.

Vaccizone has selected Exothera S.A. to fast-track process development of its SARS-CoV-2 vaccine for European clinical trials.

Ubiquigent Limited has announced the expansion of its Scientific Advisory Board with the appointments of Professor Helen Walden and Professor John Davis.

Biosynth Carbosynth announces today the acquisition of Pepscan.

Lonza today announced plans to construct a large-scale commercial drug product fill and finish facility in Stein (CH).

Lonza today announced that its Board of Directors has appointed Maria Soler Nunez as the new Head, Group Operations.

Avacta Group plc announces that the first-in-human Phase I trial of AVA6000 Pro-doxorubicin will advance to the third dose cohort following a positive review of the safety data from the dosing of the second cohort.

NovaXS Biotech Corp, developers of an in-home and needle-free drug delivery platform, for the first time unveiled its new prototype of its needle-free injection therapy smart medical device.

BUCHI Labortechnik has launched the Mini Spray Dryer S-300, a new generation of spray drying systems.

Lucius Partners, LLC has reported that its portfolio company, Voltron Therapeutics, Inc., had announced the initiation of a preclinical study of its novel vaccine candidate VTX-067 in an immune-oncology model.